Clinical practice value of hematological inflammation biomarkers in nasopharyngeal carcinoma

Inflammation promotes tumor initiate, progress, invade and metastasize. Hematological inflammation biomarkers in nasopharyngeal carcinoma (peripheral blood neurtrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index and C-creative protein) are the expressions of inflammation in the progress of nasopharyngeal carcinoma. The information of prognosis can be obtained by testing the hematological inflammation biomarkers in nasopharyngeal carcinoma patients. These biomarkers are the supplement for the current prognosis predictive indices and they can be used to guide the clinical practice, which will provide more ideas. Key words: Nasopharyngeal neoplasms; Prognosis; Hematological inflammation biomarker